If a trial is effective, the provider can then begin the transition from trial to long-term treatment with opioid medications.  At the time of the transition from trial to long-term use, a full reassessment/reevaluation is to be completed.  The failure of the provider to do a reassessment/reevaluation would be a valid basis to file an objection to the treatment and raise objection to continuing and transitioning the patient from trial to long-term opioid use.  Section F.2.b.ii provides the criteria necessary for a full reevaluation, which includes but is not limited to: physical and psychological assessment; appropriate referrals based upon complications of the clinical presentation; identifying concurrent non-opioid therapies which are appropriate; a schedule for monitoring and reevaluating the opioid use; compliance with federal and state standards; and, consideration of appropriate referrals for co-morbidities.